Quality Choice

Manufacturer
Chain Drug Marketing Association | Taro Pharmaceuticals U.S.A., Inc. | Taro Pharmaceuticals Inc.
Effective date
2013-03-11
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:34:50

Label at a glance#

ProductQuality Choice 3 Day Vaginal
Active ingredientMiconazole Nitrate
Label structure11 sections

Dosage and administration

before using this product read the consumer information leaflet for complete directions and information adults and children 12 years of age and over: insert 1 applicatorful into the vagina at bedtime for 3 nights in a row. Throw applicator away after use. children under 12 years of age: ask a doctor

Storage and handling

store at 20°-25°C (68°-77°F) do not purchase if carton is open see end flaps of carton and end of tube for lot number and expiration date the tube opening should be sealed. If seal has been broken, do not use product.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each applicator)

OTC - ACTIVE INGREDIENT SECTION

Miconazole Nitrate USP 4% (200 mg in each applicator)

Purpose

OTC - PURPOSE SECTION

Vaginal antifungal

Use

INDICATIONS & USAGE SECTION

treats vaginal yeast infections

Warnings

WARNINGS SECTION

For vaginal use only

OTC - DO NOT USE SECTION

Do not use if you have never had a vaginal yeast infection diagnosed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • vaginal itching and discomfort for the first time
  • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting or foul-smelling vaginal discharge. You may have a more serious condition.
  • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system.
  • been exposed to the human immunodeficiency virus (HIV) that causes AIDS

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur

When using this product

OTC - WHEN USING SECTION

  • do not use tampons, douches, spermicides or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs).
  • do not have vaginal intercourse
  • mild increase in vaginal burning, itching or irritation may occur
  • if you do not get complete relief ask a doctor before using another product.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms do not get better in 3 days
  • symptoms last more than 7 days
  • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting or foul-smelling vaginal discharge

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • before using this product read the consumer information leaflet for complete directions and information
  • adults and children 12 years of age and over:
    • insert 1 applicatorful into the vagina at bedtime for 3 nights in a row. Throw applicator away after use.
  • children under 12 years of age: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • store at 20°-25°C (68°-77°F)
  • do not purchase if carton is open
  • see end flaps of carton and end of tube for lot number and expiration date
  • the tube opening should be sealed. If seal has been broken, do not use product.

Inactive ingredients

INACTIVE INGREDIENT SECTION

cetyl alcohol, isopropyl myristate, polysorbate 60, polysorbate 80, potassium hydroxide, propylene glycol, purified water, sorbitan monostearate and stearyl alcohol

Questions or comments?

OTC - QUESTIONS SECTION

Call toll-free, 1-800-935-2362, for our 24 hour automated response system.

SPL UNCLASSIFIED SECTION

DISTRIBUTED BY QUALITY CHOICE 43157 WEST NINE MILE ROAD
NOVI, MI 48376-0995

PRINCIPAL DISPLAY PANEL - 25 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

QC
QUALITY
CHOICE
®

Cures Most Vaginal Yeast Infections

3 Day Vaginal Cream

Miconazole Nitrate Vaginal Cream USP (4%)

Vaginal Antifungal

(Miconazole Nitrate 200 mg per applicator)

One 0.9 oz (25 g) tube of 3 Day Vaginal Cream with 3 Disposable Applicators
Consumer Information Leaflet Enclosed

PRINCIPAL DISPLAY PANEL - 25 g Tube Carton
PRINCIPAL DISPLAY PANEL - 25 g Tube Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
998544miconazole nitrate 4 % Vaginal CreamPSN1
998544miconazole nitrate 40 MG/ML Vaginal CreamSCD1
998544miconazole nitrate 4 % Vaginal CreamSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MICONAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3a55f4fb-5aec-4c88-0ff7-4d608ad4866aProduct name120140508
5b9a7965-36d2-8412-dcaf-f76a65411611Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63868-197-252020-01-31C16284748780-19d75b9d0-b422-f424-e053-dadaa90a57ceQuality Choice ® 3 Day Vaginal

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63868-197-25Quality Choice 3 Day Vaginal1 in 1 CARTONCREAM11
63868-197-25Quality Choice 3 Day Vaginal25 g in 1 TUBE, WITH APPLICATORCREAM251

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63868-197QUALITY CHOICE 3 DAY VAGINAL (MICONAZOLE NITRATE) CREAM [CHAIN DRUG MARKETING ASSOCIATION]1Legacy NDC, 2 package rows20130313_67b6e800-ed4f-4855-b7b2-266021014bd6.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63868-197-25GM - Gram63868-1979a4a3f66-5abc-4788-b078-d1ad5ef674c212013-04-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Miconazole NitrateACTIVE INGREDIENTVW4H1CYW1K1
MiconazoleACTIVE MOIETY7NNO0D7S5M1
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN1
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS1
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4M1
POLYSORBATE 80INACTIVE INGREDIENT6OZP39ZG8H1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V31
SORBITAN MONOSTEARATEINACTIVE INGREDIENTNVZ4I0H58X1
STEARYL ALCOHOLINACTIVE INGREDIENT2KR89I4H1Y1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63868-19763868-197-25

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 246 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRAVITREAL0.02 %w/vExact identifier — unii candidate
78 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii candidate
81 equally ranked IID candidates
SORBITAN MONOSTEARATESORBITAN MONOSTEARATENVZ4I0H58XSUSPENSION / ORAL62.5 mg/5mlExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / AURICULAR (OTIC)1 %w/vExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HDROPS / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
78 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TSOLUTION / ORALADJ PHExact identifier — unii candidate
13 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCAPSULE, EXTENDED RELEASE / ORAL0.07 mgExact identifier — unii candidate
13 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TGEL / TOPICAL3 mgExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUPPOSITORY / VAGINAL252 mgExact identifier — unii candidate
81 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSGEL / TRANSDERMAL85 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / OPHTHALMIC1.5 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MSUSPENSION / TOPICAL2.85 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / SOFT TISSUE4 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION / OPHTHALMIC8 mgExact identifier — unii candidate
78 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / OPHTHALMIC1 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, DELAYED RELEASE / ORAL23 mgExact identifier — unii candidate
78 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAMUSCULAR7459 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION, EXTENDED RELEASE / ORAL1000 mgExact identifier — unii candidate
81 equally ranked IID candidates
SORBITAN MONOSTEARATESORBITAN MONOSTEARATENVZ4I0H58XSUSPENSION / TOPICAL2.15 %w/wExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYSTEM / TOPICAL4200 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii candidate
81 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TINJECTION / INTRAVENOUSADJ PHExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / RECTAL27 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAVENOUS4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCAPSULE, COATED PELLETS / ORAL2 mgExact identifier — unii candidate
78 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YTABLET / ORAL20 mgExact identifier — unii candidate
12 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNAEROSOL / TOPICAL1.16 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HTABLET, EXTENDED RELEASE / ORAL10 mgExact identifier — unii candidate
78 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSUSPENSION / TOPICAL2.01 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / OPHTHALMIC1 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / AURICULAR (OTIC)10 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / RESPIRATORY (INHALATION)10 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HTABLET, COATED / ORAL18 mgExact identifier — unii candidate
78 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCREAM / VAGINAL3 mgExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / OPHTHALMIC0.44 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
SORBITAN MONOSTEARATESORBITAN MONOSTEARATENVZ4I0H58XCREAM / TOPICAL177 mgExact identifier — unii candidate
11 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TCREAM / TOPICAL0.5 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / AURICULAR (OTIC)56.55 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRASYNOVIAL4 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUPPOSITORY / VAGINAL28 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HTABLET, CHEWABLE / ORAL84 mgExact identifier — unii candidate
78 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNOINTMENT / TOPICAL7 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSUSPENSION / RESPIRATORY (INHALATION)1 mgExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HCONCENTRATE / INTRAVENOUS4680 mgExact identifier — unii candidate
78 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, COATED / ORAL0.25 mgExact identifier — unii candidate
20 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSFILM / TRANSDERMAL58.08 mgExact identifier — unii candidate
18 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSOIL / TOPICAL213 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / INTRAVENOUS5 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / INTRALESIONAL4 mgExact identifier — unii candidate
78 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TPASTILLE / ORALADJ PHExact identifier — unii candidate
13 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HINJECTION, SUSPENSION / SUBCUTANEOUS0.3 %w/vExact identifier — unii candidate
78 equally ranked IID candidates
POLYSORBATE 80POLYSORBATE 806OZP39ZG8HSOLUTION / ORAL907 mgExact identifier — unii candidate
78 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A076773-001MICONAZOLE 3MICONAZOLE NITRATE4%CREAM / VAGINAL2005-03-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02c2088c7a36db…
2026-09-14 22:38:342026-08A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-0284e616aacf4f…
2026-08-18 06:07:402026-07A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-021e350fbaab3a…
2024-05-31 18:47 UTC2024-05A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-028072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-025c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-025d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-024b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-0274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-0287673890dc5c…
2021-03-12 10:30 UTC2021-03A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-025aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-028869cabd3fbd…
2020-11-12 02:37 UTC2020-11A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02c0c555d07b60…
2019-12-14 00:12 UTC2019-12A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-023f01610625f2…
2019-09-15 20:21 UTC2019-09A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02b00525d2431f…
2019-07-19 19:46 UTC2019-07A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-026a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-021c564ffb4f44…
2023-12-20 04:57 UTC2023-12A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-029b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-023f0d92c62455…
2023-05-13 08:27 UTC2023-05A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-02053a50430f4f…
2023-01-26 05:58 UTC2023-01A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-023bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A076773-001MICONAZOLE 34%CREAM / VAGINAL2005-03-023a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8d8b54e5-1580-48a3-bb39-8e3e61a4e68f67b6e800-ed4f-4855-b7b2-266021014bd62013-03-11WarningsExact identifier
spl id: 8d8b54e5-1580-48a3-bb39-8e3e61a4e68f
spl set id: 67b6e800-ed4f-4855-b7b2-266021014bd6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.